Cancer Care Ontario | Cancer Care Ontario

375 Results

How Guidelines Are Created

Guideline Development Groups (GDGs) are brought together to work on a guideline for a specific topic. Cancer Care Ontario’s Program in Evidence-Based...

Guidelines and Advice

Hereditary Cancers Guideline: An Endorsement of the 2015 Standards and Guidelines for the Interpretation of Sequence Variants

Status: Current
ID: GL-END MOTAC 5

Aug 2017

Guidelines and Advice

Healthy Eating, Physical Activity, and Healthy Weights Guideline for Public Health in Ontario

Status: Archived
ID: 23-1

Mar 2010

Guidelines and Advice

Cancer Care Ontario Thyroid Cancer Guideline: An Endorsement of the 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer

Status: Current
ID: GL END 5-13
Version: N/A

Jun 2023

Guidelines and Advice

Consensus-based organizational guideline for the planning and delivery of spine stereotactic body radiotherapy treatment in Ontario

Status: Current
ID: GL 21-6

Apr 2023

Guidelines and Advice

Cancer Care Ontario’s Position Statement on Guidelines for Breast Cancer Well Follow-Up Care

Status: Current

Dec 2012

Guidelines and Advice

Cross-Sectional Imaging in Colorectal Cancer

Status: Archived
ID: DICRC

Sep 2012

Guidelines and Advice

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

Status: In-Review
ID: GL-END 3-21

Jan 2018

Guidelines and Advice

Computerized Prescriber Order Entry (CPOE) in the Outpatient Oncology Setting

Status: Current
ID: 12-14

May 2012

Guidelines and Advice

Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Status: Current
ID: GL 4-18
Version: N/A

Sep 2020

Guidelines and Advice

Complex surgery and perioperative systemic therapy for genitourinary cancer of the retroperitoneum

Status: Current
ID: GL 3-20
Version: N/A

Aug 2019

Guidelines and Advice

Consensus Pathology Recommendations for Mesenchymal Tumours of Soft Tissue and Bone

Status: Current
Version: 1.0

Mar 2023

How Guidelines Are Created

Hereditary Cancers Guideline: An Endorsement of the 2015 Standards and Guidelines for the Interpretation of Sequence Variants

Healthy Eating, Physical Activity, and Healthy Weights Guideline for Public Health in Ontario

Cancer Care Ontario Thyroid Cancer Guideline: An Endorsement of the 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer

Consensus-based organizational guideline for the planning and delivery of spine stereotactic body radiotherapy treatment in Ontario

Cancer Care Ontario’s Position Statement on Guidelines for Breast Cancer Well Follow-Up Care

Cross-Sectional Imaging in Colorectal Cancer

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

Computerized Prescriber Order Entry (CPOE) in the Outpatient Oncology Setting

Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Complex surgery and perioperative systemic therapy for genitourinary cancer of the retroperitoneum

Consensus Pathology Recommendations for Mesenchymal Tumours of Soft Tissue and Bone

Pages